Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

This Hedge Fund’s Picks Returned 52% in Q1 And You’ve Never Heard of It

CoStar Group Inc (NASDAQ:CSGP)

Wildcat Capital’s CoStar Group Inc (NASDAQ:CSGP) position also had a strong first-quarter and that has continued and even accelerated in the second-quarter, with shares now being up by 36% year-to-date. Solid first-quarter results and upgraded fiscal 2017 guidance released in late-April led to a surge in the stock.

CoStar Group Inc (NASDAQ:CSGP) announced the acquisition of for an undisclosed amount earlier this month, after entering into an agreement to buy the rural real estate sales platform in early-April. CoStar Group expects the acquisition to be accretive to the tune of $0.02 in non-GAAP EPS in 2017. will continue to operate as a standalone site, while its 1.4 million listings will also be distributed to some of CoStar Group’s other relevant sites like CoStar Group has built a network of sites that pulls in 7.1 million visitors monthly and plans to build on it further with additional acquisitions in the future.

Follow Costar Group Inc. (NASDAQ:CSGP)
Trade (NASDAQ:CSGP) Now!

MiMedx Group Inc (NASDAQ:MDXG)

MiMedx Group Inc (NASDAQ:MDXG) is another stock that had a decent first-quarter but an even better second-quarter. The stock is now up by 72% this year thanks to gargantuan gains of 60% over the last six-plus weeks. MiMedx Group Inc (NASDAQ:MDXG) shares started soaring in mid-April when the company preannounced some of its Q1 results, including revenue that beat estimates.

The market appears to finally be rewarding the company for its track record of strong revenue growth now that profitability is making big strides as well (operating income is projected to rise by as much as 90% this year). MiMedx has also diversified its portfolio away from just wound care treatments, which has eased concerns that its portfolio could be usurped by a competitor in one fell swoop. Craig-Hallum recently raised its price target on MiMedx to $19 from $15, suggesting there is still further room for the stock to run.

Follow Mimedx Group Inc. (NASDAQ:MDXG)
Trade (NASDAQ:MDXG) Now!

Disclosure: None

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
This is a FREE report from Insider Monkey. Credit Card is NOT required.